System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Etienne Puymirat is an expert in Cardiology at Hôpital Européen Georges-Pompidou (France). As of October 2026, ScienceLeadR ranks Etienne Puymirat in the top 1% of experts worldwide for Myocardial Ischemia and Coronary Disease. Etienne Puymirat has authored 411 publications, the most recent in 2026, and is an investigator in 34 clinical trials, 11 of them ongoing. SLR score: 1,945 (community average: 125). How the SLR is computed.

LeadR Profile

Etienne Puymirat Hôpital Européen Georges-Pompidou France
1 945 ScienceLeadR Reputation 1945

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Critical Care - Biostatistics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026
Source: PubMed

Assistance Publique - Hôpitaux de Paris

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 411

Citations

Citations: 8 638 1st author: 89 Last author: 26 Unique author: 3

Main journals

Arch Cardiovasc Dis 49
Eur Heart J 49
Archives of Cardiovascular Diseases Supplements 26
Circulation 24
Archives of cardiovascular diseases. Supplements 17

Best Journals

Circulation 11
Eur Heart J 9
N Engl J Med 7

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Use of cardiac magnetic resonance imaging after hospitalization for acute heart failure: insights from the French nationwide OFICA-2 cohort.
PMID 42769981 — guideline adherence, hospitalization, heart failure, heart, magnetic resonance imaging		Eur Heart J Imaging Methods Pract20260
Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.
PMID 42669300 — myocardial infarction, heart failure, heart, therapeutics		Lancet Top journal20262
Unsupervised clustering identifies distinct phenotypes in acute myocardial infarction: insights from the FAST-MI 2015 registry.
PMID 42689178 — registries, mortality, myocardial infarction, phenotype, classification, acute coronary syndrome, cluster analysis, precision medicine, prognosis		Front Artif Intell20260
Prospective, Single-Arm Pivotal Study for the Treatment of Subjects With Severe Symptomatic Calcific Aortic Valve Stenosis Using the Valvosoft Noninvasive Ultrasound Therapy.
PMID 42574521 — constriction, pathologic, aortic valve stenosis, cardiovascular system, aortic valve, therapeutics, blood circulation		Circulation Top journal20260
Comparison of Local Investigator and Core Laboratory Assessment of Cardiac MRI-derived Left Ventricular Ejection Fraction in the MyocarditIRM Study.
PMID 42560173 — laboratories		Radiol Cardiothorac Imaging20260

Clinical Studies 34

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

Phase 3 15
N/A 14
Phase 4 3
Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 17
Active not recruiting 5
Recruiting 5
Not yet recruiting 3
Terminated 2
Unknown 2

By type:

Interventional 27
Observational 7

By Monocentric/Multicentric:

monocentric 14
multicentric2to4 4
multicentric5to9 1
multicentricup10 15

Main Topics

Cohort/Consortium Investigators 5

Ongoing Clinical Trials

11 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
An open label extension (OLE) trial to evaluate long term safety and tolerability of pelacarsen (TQJ230)
2024-519870-38-00 — safety, cardiovascular diseases		Phase 3Not yet recruiting2026
A Phase III Study to Investigate the Risk of Incident Heart Failure and Cardiovascular Death with Baxdrostat in Combination with Dapagliflozin in Participants with Increased Risk of Developing Heart Failure
2024-514506-32-00 — heart failure, heart		Phase 3Not yet recruiting2025
Lp(a) lowering study of pelacarsen (TQJ230) with background inclisiran in participants with elevated Lp(a) and established ASCVD
2024-516356-18-00 — safety, cardiovascular diseases		Phase 3Recruiting2026
Rituximab in patients with ST elevation myocardial infarction A phase 2 placebo controlled randomized clinical trial
2022-501893-21-00 — myocardial infarction, st elevation myocardial infarction, rituximab		Phase 2Recruiting2022
DAPAgliflozine to attenuate cardiac RemOdeling afTEr aCuTe myOcardial infarction
2024-511882-13-01 — myocardial infarction, heart failure, echocardiography, therapeutics		Phase 3Active not recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS